Liver transplants for HCV infection to become obsolete in 10-20 years

In 10 to 20 years, liver transplantation will no longer be performed for patients with hepatitis C as the infection is now curable with direct-acting antiviral (DAA) therapies, says an expert at the International Digestive Disease Forum (IDDF) 2015 held recently in Hong Kong.
“Hepatitis C virus [HCV] has been the hottest topic in gastroenterology. With the new DAAs, cure rates of up to 100 percent can be achieved, in some cases without interferons,” said Professor Michael Manns of the Hannover Medical School in Hannover, Germany.
A number of DAA regimens are currently available for the treatment of different HCV genotypes. As pharmaceutical companies continue to fight for an edge in the HCV market, the grazoprevir/elbasvir combination, asunaprevir/daclatasvir/beclabuvir combination, and sofosbuvir/GS5816 combination are expected to become available in 2016, while samatasvir, sovaprevir and other promising agents are in development.
“Chronic hepatitis C has become a curable disease. Although the cure rate remains low in many parts of the world, we will be able to eliminate HCV in the next 25 years,” suggested Manns. “I’m sure in 10 to 20 years, there will be no more liver transplantations due to HCV infection.”
“Companies and researchers are on the way to leave hepatitis C and go into hepatitis B,” he continued. “At present, we can stop the progression of hepatitis B virus [HBV] infection, but a cure is not available. We need to work on strategies that interact with the covalently closed circular DNA [cccDNA] to achieve a finite duration of treatment and cure the disease.”
HBV therapies in early phases of development include viral core inhibitors, cccDNA inhibitors, entry inhibitors and immune therapies, he added.
A common challenge in eliminating HCV and HBV is the cost of new therapies, which may be unaffordable for some patients.
As liver transplantation remains in demand for various conditions, researchers are looking into alternatives to address challenges such as organ shortage and increasing donor age. One such alternative is hepatocyte transplantation.
“The liver has a high regenerative potential. Hepatocyte transplantation can therefore be developed for conditions such as acute liver failure, inborn errors of metabolism, and genetic liver diseases where we only need to replace one gene,” explained Manns.
“In Europe, for example, hepatocyte transplantation has received orphan drug status for inborn errors of urea cycle defects. The study is almost completed, and the treatment will soon be approved for this genetic liver defect,” he said.

Popular posts from this blog

PG Doctors of India must work not more than 48 Hr/week: SC

Image
As per the directives of the Honourable Supreme Court in its judgment dated,25.9.87, in writ petition No. 348-352 of 1985, all the State Governments, Medical Institutions and Universities are required to amend their rules and regulations to introduce a uniform residency scheme by 1993 “A uniform practice has to be evolved so that the discipline would be introduced. We accordingly allow the present arrangement to continue for a period of five yearsI.e. upto 1992 inclusive. For admission beginning from 1993 there would be only onepattern. All Universities and institutions shall take timely steps to bring about such amendments as may be necessary to bring statutes, regulations, and rules obtaining in their respective institutions in accord with this direction before the end of 1991 so that there may be no scope for raising of any dispute in regard to the matter.The uniform pattern has to be implemented for 1993. It is proper that one uniform system is brought into vogue throughout
Read more

Why DNB exam tougher than MS/MD exam?

Image
Guest article by Dr Kalyan R Kone   There were 6 people (accompanied by their relatives) sitting in the small waiting room outside the ward waiting for their call inside. They looked battered, tense and had such a depressed look in their eyes that even Shylock would have sympathized with them. They had cleared their DNB (Diplomate of National Board) theory exam and were making last minute preparations for their practical exam. If I were not told that they were all Doctors, I would have thought that they were all waiting for their turn to see a psychiatrist. Dr Kalyan R Kone Five out of six of those waiting doctors were appearing for the second or third time. In spite of that, they didn’t know what would be in store for them except one thing — only one or two would pass out of the six candidates. I thought for a moment that it was a good ploy by the NBE (National Board of Examination) to generate funds – after all, where would these poor guys go except appe
Read more